본문 바로가기
KERD
논문KCI 등재

Omega 3 Fatty Acids and COVID-19: A Comprehensive Review

3

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류내과학

초록

The rapid international spread of severe acute respiratory syndrome coronavirus 2 responsible for coronavirus disease 2019 (COVID-19) has posed a global health emergency in 2020. It has affected over 52 million people and led to over 1.29 million deaths worldwide, as of November 13th, 2020. Patients diagnosed with COVID-19 present with symptoms ranging from none to severe and include fever, shortness of breath, dry cough, anosmia, and gastrointestinal abnormalities. Severe complications are largely due to overdrive of the host immune system leading to “cytokine storm”. This results in disseminated intravascular coagulation, acute respiratory distress syndrome, multiple organ dysfunction syndrome, and death. Due to its highly infectious nature and concerning mortality rate, every effort has been focused on prevention and creating new medications or repurposing old treatment options to ameliorate the suffering of COVID-19 patients including the immune dysregulation. Omega-3 fatty acids are known to be incorporated throughout the body into the bi-phospholipid layer of the cell membrane leading to the production of less pro-inflammatory mediators compared to other fatty acids that are more prevalent in the Western diet. In this article, the benefits of omega-3 fatty acids, especially eicosapentaenoic acid and docosahexaenoic acid, including their anti-inflammatory, immunomodulating, and possible antiviral effects have been discussed.

Abstract

The rapid international spread of severe acute respiratory syndrome coronavirus 2 responsible for coronavirus disease 2019 (COVID-19) has posed a global health emergency in 2020. It has affected over 52 million people and led to over 1.29 million deaths worldwide, as of November 13th, 2020. Patients diagnosed with COVID-19 present with symptoms ranging from none to severe and include fever, shortness of breath, dry cough, anosmia, and gastrointestinal abnormalities. Severe complications are largely due to overdrive of the host immune system leading to “cytokine storm”. This results in disseminated intravascular coagulation, acute respiratory distress syndrome, multiple organ dysfunction syndrome, and death. Due to its highly infectious nature and concerning mortality rate, every effort has been focused on prevention and creating new medications or repurposing old treatment options to ameliorate the suffering of COVID-19 patients including the immune dysregulation. Omega-3 fatty acids are known to be incorporated throughout the body into the bi-phospholipid layer of the cell membrane leading to the production of less pro-inflammatory mediators compared to other fatty acids that are more prevalent in the Western diet. In this article, the benefits of omega-3 fatty acids, especially eicosapentaenoic acid and docosahexaenoic acid, including their anti-inflammatory, immunomodulating, and possible antiviral effects have been discussed.

참고문헌 (86)

  1. Hui DS, "The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-The latest 2019 novel coronavirus outbreak in Wuhan, China", Int J Infect Dis, 91, pp.264~266 (2020)
  2. "WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020"[URL]
  3. Chen N, "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China : a descriptive study", Lancet, 395, pp.507~513 (2020)
  4. "Coronavirus disease 2019 (COVID-19) Situation Report 26"[URL]
  5. 최준용, "Convalescent Plasma Therapy for Coronavirus Disease 2019", Infection and Chemotherapy, 52(3), pp.307~316 (2020), 대한감염학회[DOI]
  6. "Coronavirus resource center. COVID-19 Map"[URL]
  7. Li H, "Coronavirus disease 2019(COVID-19) : current status and future perspectives", Int J Antimicrob Agents, 55, pp.105951~ (2020)
  8. McClaskey EM, "Subdural hematoma after a fall in an elderly patient taking high-dose omega-3 fatty acids with warfarin and aspirin : case report and review of the literature", Pharmacotherapy, 27, pp.152~160 (2007)
  9. Gutiérrez S, "Effects of omega-3 fatty acids on immune cells", Int J Mol Sci, 20, pp.5028~ (2019)
  10. Saifullah A, "Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study", Nephrol Dial Transplant, 22, pp.3561~3567 (2007)
  11. Albert CM, "Fish consumption and risk of sudden cardiac death", JAMA, 279, pp.23~28 (1998)
  12. Yang X, "Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China : a single-centered, retrospective, observational study", Lancet Respir Med, 8, pp.475~481 (2020)
  13. Malik YA, "Properties of Coronavirus and SARS-CoV-2", Malays J Pathol, 42, pp.3~11 (2020)
  14. Woo PC, "Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus", J Virol, 86, pp.3995~4008 (2012)
  15. Cui J, "Origin and evolution of pathogenic coronaviruses", Nat Rev Microbiol, 17, pp.181~192 (2019)
  16. Carod-Artal FJ, "Neurological complications of coronavirus and COVID-19", Rev Neurol, 70, pp.311~322 (2020)
  17. Fani M, "Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARSCoV and MERS-CoV infections", Future Virol (2020)
  18. Wang H, "The genetic sequence, origin, and diagnosis of SARSCoV-2", Eur J Clin Microbiol Infect Dis, 39, pp.1629~1635 (2020)
  19. Schröder I, "COVID-19 : a risk assessment perspective", ACS Chem Health Saf, 27, pp.160~169 (2020)
  20. Yadav T, "Transmission cycle of SARS-CoV and SARS-CoV-2. Coronavirus Disease 2019(COVID-19)", 33~42 (2020)
  21. Ceccarelli M, "Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet?", Eur Rev Med Pharmacol Sci, 24, pp.2781~2783 (2020)
  22. "COVID-19 vs. SARS: how do they differ?"[URL]
  23. Petrosillo N, "COVID-19, SARS and MERS: are they closely related?", Clin Microbiol Infect, 26, pp.729~734 (2020)
  24. Verdecchia P, "The pivotal link between ACE2 deficiency and SARSCoV-2 infection", Eur J Intern Med, 76, pp.14~20 (2020)
  25. "The Cell Biology of SARS-CoV-2: Anthony Futerman"[URL]
  26. Kaul D, "An overview of coronaviruses including the SARS-2 coronavirus-Molecular biology, epidemiology and clinical implications", Curr Med Res Pract, 10, pp.54~64 (2020)
  27. Satija N, "The molecular biology of SARS coronavirus", Ann N Y Acad Sci, 1102, pp.26~38 (2007)
  28. Yang D, "The structure and functions of coronavirus genomic 3′ and 5′ ends", Virus Res, 206, pp.120~133 (2015)
  29. Shang J, "Structural basis of receptor recognition by SARS-CoV-2", Nature, 581, pp.221~224 (2020)
  30. Li F, "Structure, function, and evolution of coronavirus spike proteins", Annu Rev Virol, 3, pp.237~261 (2016)
  31. "What we now know about coronavirus transmission: where the virus goes in your body and how it is spread"[URL]
  32. Hoffmann M, "SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor", Cell, 181, pp.271~280 (2020)
  33. Rothan HA, "The epidemiology and pathogenesis of coronavirus disease(COVID-19)outbreak", J Autoimmun, 109, pp.102433~ (2020)
  34. Xu Y, "Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding", Nat Med, 26, pp.502~505 (2020)
  35. Qu G, "An imperative need for research on the role of environmental factors in transmission of novel coronavirus(COVID-19)", Environ Sci Technol, 54, pp.3730~3732 (2020)
  36. van Doremalen N, "Aerosol and surface stability of HCoV-19(SARS-CoV-2)compared to SARS-CoV-1", N Engl J Med, 382, pp.1564~1567 (2020)
  37. "Coronavirus Disease 2019 (COVID-19): People at increased risk"[URL]
  38. Marhl M, "Diabetes and metabolic syndrome as risk factors for COVID-19", Diabetes Metab Syndr, 14, pp.671~677 (2020)
  39. Ruxton CH, "The health benefits of omega-3 polyunsaturated fatty acids : a review of the evidence", J Hum Nutr Diet, 17, pp.449~459 (2004)
  40. Calder PC, "Omega-3 polyunsaturated fatty acids and inflammatory processes : nutrition or pharmacology", Br J Clin Pharmacol, 75, pp.645~662 (2013)
  41. Lin PY, "A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids", J Clin Psychiatry, 68, pp.1056~1061 (2007)
  42. Maroon JC, "Omega-3 fatty acids(fish oil)as an anti-inflammatory : an alternative to nonsteroidal anti-inflammatory drugs for discogenic pain", Surg Neurol, 65, pp.326~331 (2006)
  43. Ishihara T, "Omega-3 fatty acid-derived mediators that control inflammation and tissue homeostasis", Int Immunol, 31, pp.559~567 (2019)
  44. Chanda W, "Effectiveness of omega-3 polyunsaturated fatty acids against microbial pathogens", J Zhejiang Univ Sci B, 19, pp.253~262 (2018)
  45. Ward OP, "Omega-3", 6 fatty acids : alternative sources of production, 2005, pp.40, 3627~3652
  46. Richter CK, "Total long-chain n-3 fatty acid intake and food sources in the United States compared to recommended intakes : NHANES 2003-2008", Lipids, 52, pp.917~927 (2017)
  47. Innes JK, "Marine omega-3(N-3)fatty acids for cardiovascular health : an update for 2020", Int J Mol Sci, 21, pp.1362~ (2020)
  48. Burri L, "Marine omega-3 phospholipids : metabolism and biological activities", Int J Mol Sci, 13, pp.15401~15419 (2012)
  49. "Office of dietary supplements: Omega-3 fatty acids"[URL]
  50. Punia S, "Omega 3-metabolism, absorption, bioavailability and health benefits-A review", PharmaNutrition, 10, pp.100162~ (2019)
  51. Cholewski M, "A comprehensive review of chemistry, sources and bioavailability of omega-3 fatty acids", Nutrients, 10, pp.1662~ (2018)
  52. "Omega-3-carboxylic acids"[URL]
  53. Calder PC, "Mechanisms of action of(n-3)fatty acids", J Nutr, 142, pp.592S~599S (2012)
  54. Kiefer D, "Omega-3 fatty acids : An update emphasizing clinical use", Agro Food Ind Hi-Tech, 23, pp.10~13 (2012)
  55. "Essential fatty acids"[URL]
  56. "Omega-3 & Omega-6 fatty acid synthesis, metabolism, functions"[URL]
  57. Zhang MM, "The efficacy and safety of omega-3fatty acids on depressive symptoms in perinatal women : a meta-analysis of randomized placebocontrolled trials", Transl Psychiatry, 10, pp.193~ (2020)
  58. Calder PC, "Fatty acids and inflammation: the cutting edge between food and pharma", Eur J Pharmacol, 668(Suppl 1), pp.S50~S58 (2011)
  59. Kris-Etherton PM, "American Heart Association. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association", Arterioscler Thromb Vasc Biol, 23, pp.151~152 (2003)
  60. Gross BW, "Omega-3 fatty acid supplementation and warfarin : a lethal combination in traumatic brain injury", J Trauma Nurs, 24, pp.15~18 (2017)
  61. Sheppard KW, "Omega-6", omega-3 fatty acid intake of children and older adults in the U.S.:dietary intake in comparison to current dietary recommendations and the Healthy Eating Index, 2018, pp.17, 43~
  62. Simopoulos AP, "The importance of the ratio of omega-6", omega-3 essential fatty acids, 2002, pp.56, 365~379
  63. Innes JK, "Omega-6 fatty acids and inflammation", Prostaglandins Leukot Essent Fatty Acids, 132, pp.41~48 (2018)
  64. Körner A, "Resolution of inflammation and sepsis survival are improved by dietary Ω-3 fatty acids", Cell Death Differ, 25, pp.421~431 (2018)
  65. Saedisomeolia A, "Anti-inflammatory effects of long-chain n-3PUFA in rhinovirus-infected cultured airway epithelial cells", Br J Nutr, 101, pp.533~540 (2009)
  66. Sakai C, "Fish oil omega-3polyunsaturated fatty acids attenuate oxidative stress-induced DNA damage in vascular endothelial cells", PLoS One, 12, pp.e0187934~ (2017)
  67. "Omega-3 shows benefits against ‘oxidative stress’: Study"[URL]
  68. Meital LT, "Omega-3 fatty acids decrease oxidative stress and inflammation in macrophages from patients with small abdominal aortic aneurysm", Sci Rep, 9, pp.12978~ (2019)
  69. Eslamloo K, "Transcriptome profiling of antiviral immune and dietary fatty acid dependent responses of Atlantic salmon macrophage-like cells", BMC Genomics, 18, pp.706~ (2017)
  70. Wall R, "Fatty acids from fish : the anti-inflammatory potential of longchain omega-3 fatty acids", Nutr Rev, 68, pp.280~289 (2010)
  71. Mathru M, "Yearbook of Anesthesiology and Pain Management 2009", pp.147~ (2009)
  72. Chanda W, "Effectiveness of omega-3 polyunsaturated fatty acids against microbial pathogens", J Zhejiang Univ Sci B, 19, pp.253~262 (2018)
  73. Kang KW, "Endogenous n-3 polyunsaturated fatty acids are beneficial to dampen CD8+ T cell-mediated inflammatory response upon the viral infection in mice", Int J Mol Sci, 20, pp.4510~ (2019)
  74. Shahidi F, "Omega-3 polyunsaturated fatty acids and their health benefits", Annu Rev Food Sci Technol, 9, pp.345~381 (2018)
  75. Messina G, "Functional role of dietary intervention to improve the outcome of COVID-19 : a hypothesis of work", Int J Mol Sci, 21, pp.3104~ (2020)
  76. Harris WS, "Omega-3 fatty acids and cardiovascular disease : a case for omega-3 index as a new risk factor", Pharmacol Res, 55, pp.217~223 (2007)
  77. Hamimi A, "MERS-CoV : Middle East respiratory syndrome corona virus : can radiology be of help? Initial single center experience", Egypt J Radiol Nucl Med, 47, pp.95~106 (2016)
  78. "How do SARS and MERS compare with COVID-19?"[URL]
  79. "Coronaviruses and acute respiratory syndromes (COVID-19, MERS, and SARS)"[URL]
  80. "What is coronavirus? The different types of coronaviruses"[URL]
  81. "Scientists compare novel coronavirus with SARS and MERS viruses"[URL]
  82. Mousavizadeh L, "Genotype and phenotype of COVID-19: Their roles in pathogenesis", J Microbiol Immunol Infect (2020)
  83. "Severe acute respiratory syndrome (SARS)"[URL]
  84. Miles EA, "Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis", Br J Nutr, 107(Suppl 2), pp.S171~S184 (2012)
  85. Li X, "Therapeutic potential of ω-3 polyunsaturated fatty acids in human autoimmune diseases", Front Immunol, 10, pp.2241~ (2019)
  86. Pellegrini M, "The role of nutrition and nutritional supplements in ocular surface diseases", Nutrients, 12, pp.952~ (2020)

관련 논문AI추천

Role of n-3 long-chain polyunsaturated fatty acids in human nutrition and health: review of recent studies and recommendationsPeter Van Dael한국영양학회 · Nutrition Research and Practice2021 · 제15권 제2호Association between serum fatty acid composition and innate immune markers in healthy adultsEunyu Cho, Yongsoon Park한국영양학회 · Nutrition Research and Practice2016 · 제10권 제2호The Effect of Omega-3 Supplementation on Heart Failure Outcome: A Meta-Analysis of Randomized Clinical TrialAde Meidian Ambari, Anwar Santoso, Bambang Dwiputra, Bashar Adi Wahyu Pandhita, Basuni Radi, Budhi Setianto Purwowiyoto, Dwita Rian Desandri, Serlie Fatrin한국지질동맥경화학회 · 지질·동맥경화학회지2024 · 제13권 제2호Can Nutritional Supports Beneficial in Other Viral Diseases Be Favorable for COVID-19?Fatmanur Zehra Zelka, Mesut Karahan, Öznur Özge Özcan, Rümeysa Rabia Kocatürk대한가정의학회 · Korean Journal of Family Medicine2022 · 제43권 제1호Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) in Endurance Performance and Cardiovascular FunctionEisuke Ochi, Yosuke Tsuchiya한국운동생리학회 · 운동과학2019 · 제28권 제4호Common and differential effects of docosahexaenoic acid and eicosapentaenoic acid on helper T-cell responses and associated pathways강석민, 박성하, 안수진, 이상학, 이찬주, Ichiro Manabe, Jaeho Lee, Jaewon Oh, Jung Mi Park, Miso Kim, Moonjong Kang, Yu Ri Choi생화학분자생물학회 · BMB Reports2021 · 제54권 제5호

이 간행물의 다른 논문 (20건)